Hub : Traits :

Ulcerative Colitis

218 significantly associated models · 82 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 1781220 3219950 7 1 7.9e-10 8.0e-10 0.02180 86 RP3-395M20.9
2 1 7314655 8738937 2 1 3.2e-08 2.3e-09 0.01850 84 PARK7
3 1 19515061 21114833 2 3 1.5e-23 4.9e-31 0.85300 100 OTUD3 PLA2G5
4 1 160642451 162039394 3 2 2.7e-17 3.8e-17 0.01130 91 FCGR2A RP11-122G18.5
5 2 60466491 62087165 3 1 8.9e-11 1.8e-12 0.00527 84 PEX13
6 2 199443880 201021954 1 1 2.6e-07 2.3e-07 1.00000 100 SATB2
7 2 218382236 219846749 4 1 1.0e-08 2.0e-07 0.20800 94 AAMP
8 3 47911521 50932324 25 1 2.6e-14 2.3e-15 1.00000 100 FAM212A
9 4 122842267 123530993 1 1 1.2e-07 3.1e-06 0.00931 69 KIAA1109
10 5 131008194 132425049 1 1 1.6e-07 4.9e-06 0.28100 94 SLC22A5
11 5 158501850 159005439 1 1 2.3e-08 1.1e-09 0.01420 84 IL12B
12 6 116091635 117481404 1 1 2.0e-07 6.2e-07 0.16100 92 FAM26F
13 7 2032803 3510741 1 1 1.1e-08 1.2e-08 0.31500 97 AMZ1
14 7 5726022 7141565 1 1 2.0e-07 2.3e-05 0.82200 100 RAC1
15 7 106847492 108340749 3 1 9.9e-16 1.7e-15 0.00924 89 DLD
16 7 127878155 129284182 1 1 3.4e-09 2.9e-07 0.47200 98 IRF5
17 9 138558883 140071683 6 2 7.1e-15 5.8e-13 0.14800 96 CARD9 INPP5E
18 17 37137299 39048774 8 1 1.9e-10 9.2e-12 0.00996 86 RAPGEFL1
19 20 61576647 62912463 6 1 2.8e-11 3.4e-08 0.53600 99 RTEL1
20 21 45398656 45902320 1 1 2.1e-08 7.1e-11 0.00027 69 ICOSLG
21 22 49656585 51055900 1 1 1.6e-07 2.4e-08 1.00000 100 PIM3

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder or Schizophrenia 1.41 1 0 0.0 0.00 1.0e+00 RP3-395M20.9
Depressed Affect (Nagel 2018) 1.65 1 1 2.2 0.00 1.0e+00 FAM212A
Intelligence (Savage-Jansen 2018) 1.96 1 1 2.2 0.00 1.0e+00 FAM212A
Worry (Nagel 2018) 1.21 1 0 0.0 0.00 1.0e+00 SATB2
Crohns Disease (2017) 14.15 11 9 20.0 0.97 1.5e-06 CARD9 FAM212A ICOSLG IL12B INPP5E KIAA1109 PARK7 PEX13 RAPGEFL1 RTEL1 SLC22A5
Irritable Bowel Disease (IBD) 24.25 22 17 37.8 0.95 1.1e-11 AAMP AMZ1 CARD9 DLD FAM212A FCGR2A ICOSLG IL12B INPP5E KIAA1109 OTUD3 PARK7 PEX13 PIM3 PLA2G5 RAC1 RAPGEFL1 RP11-122G18.5 RP3-395M20.9 RTEL1 SATB2 SLC22A5
Ulcerative Colitis (UC) 26.23 24 18 40.0 0.99 3.7e-20 AAMP AMZ1 CARD9 DLD FAM212A FAM26F FCGR2A ICOSLG IL12B INPP5E IRF5 KIAA1109 OTUD3 PARK7 PEX13 PIM3 PLA2G5 RAC1 RAPGEFL1 RP11-122G18.5 RP3-395M20.9 RTEL1 SATB2 SLC22A5
Verbal and Numeric Reasoning (VNR) 1.74 1 1 2.2 0.00 1.0e+00 FAM212A
Breast Cancer 1.43 3 0 0.0 0.00 1.0e+00 FAM212A PARK7 SLC22A5
Prostate Cancer 2.24 2 0 0.0 0.00 1.0e+00 FAM212A RTEL1
Age at First Birth 1.97 1 1 2.2 0.00 1.0e+00 FAM212A
Body Mass Index (BMI) (2010) 1.46 1 0 0.0 0.00 1.0e+00 RP3-395M20.9
Crohns Disease (2012) 10.15 7 7 15.6 0.97 2.3e-04 FAM212A ICOSLG IL12B PEX13 RAPGEFL1 RTEL1 SLC22A5
HDL Cholesterol 1.74 2 1 2.2 0.00 1.0e+00 RAC1 RAPGEFL1
LDL Cholesterol 0.96 1 0 0.0 0.00 1.0e+00 FCGR2A
Lupus 4.07 2 2 4.4 0.00 1.0e+00 FCGR2A IRF5
Primary Biliary Cirrhosis 2.85 2 1 2.2 0.00 1.0e+00 IRF5 RAPGEFL1
Rheumatoid Arthritis 2.68 1 0 0.0 0.00 1.0e+00 FCGR2A
Schizophrenia (2014) 1.14 1 0 0.0 0.00 1.0e+00 FCGR2A
Blood Eosinophil Count 4.45 5 4 8.9 -0.29 6.4e-01 AMZ1 IRF5 KIAA1109 RP3-395M20.9 SLC22A5
Blood Platelet Count 1.72 7 5 11.1 -0.52 2.3e-01 AAMP AMZ1 IRF5 PARK7 RP11-122G18.5 RTEL1 SLC22A5
Blood Red Count 0.59 2 1 2.2 0.00 1.0e+00 FCGR2A RTEL1
Blood White Count 10.68 9 8 17.8 -0.43 2.5e-01 AAMP AMZ1 CARD9 FAM212A INPP5E PEX13 RAPGEFL1 RTEL1 SLC22A5
Heel T-Score 1.00 6 2 4.4 -0.41 4.2e-01 AAMP AMZ1 FAM212A IRF5 RAC1 SATB2
BMI 1.56 3 1 2.2 0.00 1.0e+00 FAM212A RP3-395M20.9 RTEL1
Height 3.41 9 8 17.8 0.45 2.3e-01 AAMP AMZ1 CARD9 FAM212A FAM26F INPP5E IRF5 PARK7 SLC22A5
Waist Hip Ratio (WHR) 0.84 2 1 2.2 0.00 1.0e+00 AAMP DLD
Systolic Blood Pressure 0.92 3 1 2.2 0.00 1.0e+00 AAMP FAM212A RAC1
Smoking Status 1.47 1 1 2.2 0.00 1.0e+00 RTEL1
Allergy or Eczema 6.04 6 4 8.9 0.43 3.9e-01 AMZ1 KIAA1109 PEX13 RAPGEFL1 RTEL1 SLC22A5
Cardiovascular Disease 1.30 1 0 0.0 0.00 1.0e+00 SLC22A5
Hypothyroidism (self reported) 1.47 2 0 0.0 0.00 1.0e+00 KIAA1109 PEX13
Respiratory disease 8.10 4 3 6.7 -0.66 3.4e-01 KIAA1109 RAPGEFL1 RTEL1 SLC22A5
Lung FEV1/FVC ratio 1.90 4 3 6.7 0.44 5.6e-01 AMZ1 FAM212A RAPGEFL1 SLC22A5
Lung FVC 2.21 7 5 11.1 -0.15 7.6e-01 AAMP CARD9 FAM212A PARK7 RTEL1 SATB2 SLC22A5
Neuroticism 1.21 2 0 0.0 0.00 1.0e+00 FAM212A SATB2
Chronotype (morning person) 1.80 2 0 0.0 0.00 1.0e+00 KIAA1109 PARK7
Tanning 0.13 1 0 0.0 0.00 1.0e+00 PIM3
Hand grip strength (left) 1.70 3 0 0.0 0.00 1.0e+00 AMZ1 FCGR2A SLC22A5
Number of treatments/medications taken 2.16 1 1 2.2 0.00 1.0e+00 FAM212A
Average weekly spirits intake 1.82 1 0 0.0 0.00 1.0e+00 FAM212A
Hearing difficulty/problems: Yes 1.40 1 0 0.0 0.00 1.0e+00 SATB2
Relative age of first facial hair 1.22 1 0 0.0 0.00 1.0e+00 SATB2
Systolic blood pressure, automated reading 0.92 1 0 0.0 0.00 1.0e+00 FAM212A
Medication: Co-codamol 1.78 1 0 0.0 0.00 1.0e+00 FAM212A
Diabetes (father) 1.51 1 0 0.0 0.00 1.0e+00 PIM3
Impedance of leg (right) 0.63 1 0 0.0 0.00 1.0e+00 RP11-122G18.5
Leg fat-free mass (left) 2.37 4 2 4.4 0.95 4.8e-02 AAMP AMZ1 FAM212A PARK7
Trunk fat percentage 1.88 4 2 4.4 0.48 5.2e-01 AMZ1 FAM212A RP3-395M20.9 RTEL1
Hand grip strength (right) 1.70 2 0 0.0 0.00 1.0e+00 FCGR2A SLC22A5
Current tobacco smoking 1.70 1 1 2.2 0.00 1.0e+00 RTEL1
Fed-up feelings 1.73 1 1 2.2 0.00 1.0e+00 FAM212A
Relative age voice broke 1.21 1 0 0.0 0.00 1.0e+00 SATB2
Taking other prescription medications 2.95 2 1 2.2 0.00 1.0e+00 FAM212A RAPGEFL1
Age when periods started (menarche) 2.90 3 1 2.2 0.00 1.0e+00 FAM212A IRF5 SATB2
High blood pressure 0.88 1 0 0.0 0.00 1.0e+00 SLC22A5
Hayfever, allergic rhinitis or eczema 6.10 5 4 8.9 0.27 6.6e-01 KIAA1109 PEX13 RAPGEFL1 RTEL1 SLC22A5
Medication: Levothyroxine sodium 1.67 1 0 0.0 0.00 1.0e+00 PEX13
Sitting height 3.19 6 6 13.3 0.62 1.9e-01 AAMP AMZ1 CARD9 FAM26F INPP5E PARK7
Body mass index (BMI) 1.63 2 1 2.2 0.00 1.0e+00 FAM212A RTEL1
Leg predicted mass (left) 2.35 4 2 4.4 0.95 4.6e-02 AAMP AMZ1 FAM212A PARK7
Trunk fat mass 2.43 3 2 4.4 0.00 1.0e+00 AMZ1 FAM212A RTEL1
Waist circumference 1.82 3 2 4.4 0.00 1.0e+00 AMZ1 FAM212A RTEL1
Nervous feelings 1.03 1 0 0.0 0.00 1.0e+00 SATB2
Frequency of tenseness / restlessness in last 2 weeks 1.10 1 0 0.0 0.00 1.0e+00 FAM212A
Forced vital capacity (FVC) 1.93 5 3 6.7 0.46 4.4e-01 AAMP AMZ1 FAM212A RTEL1 SATB2
Qualifications: None of the above 1.65 1 1 2.2 0.00 1.0e+00 FAM212A
Allergy 7.29 6 4 8.9 -0.20 7.0e-01 AMZ1 KIAA1109 PEX13 RAPGEFL1 RTEL1 SLC22A5
Pain all over the body in last month 1.89 1 0 0.0 0.00 1.0e+00 FAM212A
Hayfever/allergic rhinitis (self-reported) 2.77 2 1 2.2 0.00 1.0e+00 KIAA1109 RAPGEFL1
Fluid intelligence score 1.74 1 1 2.2 0.00 1.0e+00 FAM212A
Weight 2.64 3 2 4.4 0.00 1.0e+00 AMZ1 FAM212A PARK7
Impedance of arm (right) 1.51 5 1 2.2 0.64 2.4e-01 AMZ1 FAM212A RAC1 RAPGEFL1 SATB2
Arm fat percentage (right) 1.41 3 1 2.2 0.00 1.0e+00 AMZ1 FAM212A RTEL1
Trunk fat-free mass 2.39 6 3 6.7 0.56 2.4e-01 AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Hip circumference 2.32 4 2 4.4 0.65 3.5e-01 AMZ1 FAM212A PARK7 RTEL1
Alcohol intake versus 10 years previously 1.80 1 1 2.2 0.00 1.0e+00 FAM212A
Father's age at death 1.64 1 0 0.0 0.00 1.0e+00 FAM212A
Worrier / anxious feelings 1.05 1 0 0.0 0.00 1.0e+00 SATB2
Forced expiratory volume in 1-second (FEV1) 1.65 3 2 4.4 0.00 1.0e+00 AAMP FAM212A RTEL1
Qualifications: A levels/AS levels or equivalent 2.54 1 1 2.2 0.00 1.0e+00 FAM212A
Mouth/teeth dental problems: Dentures 1.41 1 0 0.0 0.00 1.0e+00 FAM212A
Asthma 7.52 3 3 6.7 0.00 1.0e+00 KIAA1109 RAPGEFL1 SLC22A5
Forced expiratory volume in 1-second (FEV1), Best measure 1.68 4 1 2.2 0.59 4.1e-01 AAMP FAM212A ICOSLG SATB2
Impedance of arm (left) 1.64 5 1 2.2 0.66 2.3e-01 AMZ1 FAM212A RAC1 RAPGEFL1 SATB2
Arm fat mass (right) 1.91 3 2 4.4 0.00 1.0e+00 AMZ1 FAM212A RTEL1
Trunk predicted mass 2.36 6 3 6.7 0.56 2.5e-01 AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Standing height 3.38 8 6 13.3 0.44 2.8e-01 AAMP AMZ1 CARD9 FAM26F INPP5E IRF5 PARK7 SLC22A5
Birth weight of first child 1.48 1 0 0.0 0.00 1.0e+00 RAC1
Qualifications: O levels/GCSEs or equivalent 1.57 1 0 0.0 0.00 1.0e+00 FAM212A
Medication: Paracetamol 1.19 1 0 0.0 0.00 1.0e+00 FAM212A
Hypothyroidism/myxoedema (self-reported) 1.56 1 0 0.0 0.00 1.0e+00 KIAA1109
Medication: Ventolin 100micrograms inhaler 4.05 2 2 4.4 0.00 1.0e+00 KIAA1109 RAPGEFL1
Birth weight 2.20 2 1 2.2 0.00 1.0e+00 AMZ1 PIM3
Forced vital capacity (FVC), Best measure 1.87 5 2 4.4 0.51 3.8e-01 AAMP AMZ1 FAM212A RTEL1 SATB2
Body fat percentage 1.81 4 2 4.4 0.28 7.2e-01 AMZ1 FAM212A RP3-395M20.9 RTEL1
Leg fat percentage (right) 1.93 3 2 4.4 0.00 1.0e+00 FAM212A RP3-395M20.9 RTEL1
Arm fat-free mass (right) 2.35 5 3 6.7 0.39 5.2e-01 AAMP AMZ1 CARD9 FAM212A PARK7
Worry too long after embarrassment 1.27 1 0 0.0 0.00 1.0e+00 PEX13
Wheeze or whistling in the chest in last year 4.30 4 4 8.9 -0.59 4.1e-01 FAM212A KIAA1109 RAPGEFL1 RTEL1
Age at first live birth 1.59 1 1 2.2 0.00 1.0e+00 FAM212A
Qualifications: College or University degree 2.83 3 1 2.2 0.00 1.0e+00 FAM212A PEX13 RTEL1
Emphysema/chronic bronchitis 2.14 1 0 0.0 0.00 1.0e+00 RAPGEFL1
Medication: Seretide 50 evohaler 2.63 2 0 0.0 0.00 1.0e+00 FAM212A KIAA1109
Whole body fat mass 2.35 3 2 4.4 0.00 1.0e+00 AMZ1 FAM212A RTEL1
Leg fat mass (right) 2.17 4 2 4.4 0.26 7.4e-01 AMZ1 FAM212A RP3-395M20.9 RTEL1
Arm predicted mass (right) 2.44 5 3 6.7 0.38 5.2e-01 AAMP AMZ1 CARD9 FAM212A PARK7
Pulse rate, automated reading 0.99 1 0 0.0 0.00 1.0e+00 FAM212A
Alcohol intake frequency. 0.86 1 0 0.0 0.00 1.0e+00 FAM212A
Comparative height size at age 10 2.76 5 3 6.7 0.71 1.8e-01 AAMP AMZ1 CARD9 INPP5E SLC22A5
Suffer from 'nerves' 1.54 1 1 2.2 0.00 1.0e+00 SATB2
Overall health rating 1.98 2 1 2.2 0.00 1.0e+00 AMZ1 FAM212A
Chest pain or discomfort 1.41 1 0 0.0 0.00 1.0e+00 RAPGEFL1
Age at last live birth 1.86 1 1 2.2 0.00 1.0e+00 FAM212A
Leg pain on walking 1.25 1 0 0.0 0.00 1.0e+00 FAM212A
Forced expiratory volume in 1-second (FEV1), predicted 2.26 2 1 2.2 0.00 1.0e+00 AMZ1 CARD9
Whole body fat-free mass 2.43 6 3 6.7 0.55 2.6e-01 AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Leg fat-free mass (right) 2.32 5 1 2.2 0.46 4.4e-01 AAMP AMZ1 CARD9 FAM212A PARK7
Arm fat percentage (left) 1.50 4 2 4.4 0.19 8.1e-01 AMZ1 FAM212A RP3-395M20.9 RTEL1
Mood swings 1.16 1 1 2.2 0.00 1.0e+00 FAM212A
Loneliness, isolation 1.21 1 0 0.0 0.00 1.0e+00 FAM212A
Qualifications: nursing, teaching 1.52 1 0 0.0 0.00 1.0e+00 FAM212A
Mouth/teeth dental problems: Mouth ulcers 2.44 3 1 2.2 0.00 1.0e+00 IL12B IRF5 RAPGEFL1
Asthma (self-reported) 7.57 3 3 6.7 0.00 1.0e+00 KIAA1109 RAPGEFL1 SLC22A5
Smoking status: Current 1.56 1 0 0.0 0.00 1.0e+00 RTEL1
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.59 2 0 0.0 0.00 1.0e+00 AMZ1 RAPGEFL1
Whole body water mass 2.39 6 3 6.7 0.55 2.6e-01 AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Leg predicted mass (right) 2.32 5 1 2.2 0.45 4.4e-01 AAMP AMZ1 CARD9 FAM212A PARK7
Arm fat mass (left) 1.91 3 2 4.4 0.00 1.0e+00 AMZ1 FAM212A RTEL1
Number of self-reported non-cancer illnesses 1.92 1 0 0.0 0.00 1.0e+00 RAPGEFL1
Miserableness 1.84 2 1 2.2 0.00 1.0e+00 FAM212A RAPGEFL1
Guilty feelings 1.23 1 0 0.0 0.00 1.0e+00 FAM212A
Financial situation satisfaction 1.05 1 0 0.0 0.00 1.0e+00 FAM212A
Medication: Paracetamol 1.26 1 0 0.0 0.00 1.0e+00 FAM212A
Basal metabolic rate 2.53 5 3 6.7 0.41 4.9e-01 AAMP AMZ1 CARD9 FAM212A PARK7
Leg fat percentage (left) 1.97 3 2 4.4 0.00 1.0e+00 FAM212A RP3-395M20.9 RTEL1
Arm fat-free mass (left) 2.37 6 3 6.7 0.49 3.3e-01 AAMP AMZ1 CARD9 FAM212A INPP5E PARK7
Number of operations (self-reported) 2.46 2 1 2.2 0.00 1.0e+00 AMZ1 PARK7
Average weekly beer plus cider intake 1.31 1 0 0.0 0.00 1.0e+00 FAM212A
Diastolic blood pressure, automated reading 1.47 2 1 2.2 0.00 1.0e+00 FAM212A RTEL1
Unable to work because of sickness or disability 0.93 1 0 0.0 0.00 1.0e+00 DLD
Vascular/heart problems diagnosed by doctor 1.07 1 0 0.0 0.00 1.0e+00 SLC22A5
Medication: Omeprazole (e.g. Zanprol) 1.51 1 0 0.0 0.00 1.0e+00 SATB2
Pain experienced in last month 1.48 1 0 0.0 0.00 1.0e+00 FAM212A
Impedance of whole body 0.99 2 1 2.2 0.00 1.0e+00 FAM212A SATB2
Leg fat mass (left) 2.23 4 2 4.4 0.25 7.5e-01 AMZ1 FAM212A RP3-395M20.9 RTEL1
Arm predicted mass (left) 2.45 6 3 6.7 0.48 3.4e-01 AAMP AMZ1 CARD9 FAM212A INPP5E PARK7

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 2 0.060 1.5
GTEx Adipose Visceral Omentum 5 0.254 1.5
GTEx Adrenal Gland 1 0.071 1.6
GTEx Artery Aorta 2 0.070 1.5
GTEx Artery Coronary 1 0.088 1.6
GTEx Artery Tibial 5 0.139 1.5
GTEx Brain Caudate basal ganglia 0 0.000 1.5
GTEx Brain Cerebellar Hemisphere 4 0.277 1.6
GTEx Brain Cerebellum 6 0.313 1.5
GTEx Brain Cortex 1 0.100 1.6
GTEx Brain Frontal Cortex BA9 2 0.223 1.5
GTEx Brain Hippocampus 0 0.000 1.4
GTEx Brain Hypothalamus 2 0.351 1.6
GTEx Brain Nucleus accumbens basal ganglia 1 0.119 1.5
GTEx Brain Putamen basal ganglia 0 0.000 1.4
GTEx Breast Mammary Tissue 3 0.158 1.5
GTEx Breast Mammary Tissue (Male) 1 0.088 1.4
GTEx Breast Mammary Tissue (Female) 2 0.129 1.5
GTEx Cells EBV-transformed lymphocytes 5 0.364 1.7
GTEx Cells Transformed fibroblasts 6 0.148 1.5
GTEx Colon Sigmoid 1 0.071 1.6
GTEx Colon Transverse 3 0.151 1.6
GTEx Esophagus Gastroesophageal Junction 0 0.000 1.5
GTEx Esophagus Mucosa 4 0.125 1.6
GTEx Esophagus Muscularis 7 0.225 1.5
GTEx Heart Atrial Appendage 3 0.196 1.5
GTEx Heart Left Ventricle 0 0.000 1.5
GTEx Liver 0 0.000 1.5
GTEx Lung 4 0.145 1.6
GTEx Muscle Skeletal 2 0.072 1.5
GTEx Nerve Tibial 6 0.144 1.5
GTEx Ovary 1 0.114 1.6
GTEx Pancreas 1 0.063 1.5
GTEx Pituitary 0 0.000 1.6
GTEx Prostate 1 0.124 1.6
GTEx Skin Not Sun Exposed Suprapubic 3 0.126 1.5
GTEx Skin Sun Exposed Lower leg 5 0.143 1.6
GTEx Small Intestine Terminal Ileum 0 0.000 1.4
GTEx Spleen 4 0.292 1.7
GTEx Stomach 1 0.072 1.5
GTEx Testis 6 0.196 1.5
GTEx Thyroid 4 0.104 1.5
GTEx Uterus 1 0.183 1.6
GTEx Vagina 1 0.164 1.6
GTEx Whole Blood 6 0.313 1.8
METSIM Adipose 6 0.134 1.5
NTR Blood 9 0.378 1.6
ROSMAP Brain Pre-frontal Cortex 7 0.164 1.6
YFS Blood 9 0.199 1.6
CommonMind Brain Pre-frontal Cortex 6 0.114 1.5
The Cancer Genome Atlas Bladder Urothelial Carcinoma 2 0.129 1.5
The Cancer Genome Atlas Breast Invasive Carcinoma 6 0.145 1.5
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Colon Adenocarcinoma 3 0.156 1.6
The Cancer Genome Atlas Esophageal Carcinoma 1 0.155 1.4
The Cancer Genome Atlas Glioblastoma Multiforme 1 0.105 1.5
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 4 0.156 1.6
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 1 0.026 1.4
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 4 0.208 1.5
The Cancer Genome Atlas Brain Lower Grade Glioma 6 0.148 1.4
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 1 0.096 1.4
The Cancer Genome Atlas Lung Adenocarcinoma 6 0.218 1.5
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 4 0.171 1.5
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 1 0.067 1.5
The Cancer Genome Atlas Pancreatic Adenocarcinoma 6 0.382 1.5
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 2 0.162 1.5
The Cancer Genome Atlas Prostate Adenocarcinoma 6 0.138 1.5
The Cancer Genome Atlas Rectum Adenocarcinoma 1 0.151 1.5
The Cancer Genome Atlas Soft Tissue Sarcoma 1 0.101 1.5
The Cancer Genome Atlas Skin Cutaneous Melanoma 0 0.000 1.5
The Cancer Genome Atlas Stomach Adenocarcinoma 1 0.063 1.4
The Cancer Genome Atlas Testicular Germ Cell Tumors 1 0.083 1.6
The Cancer Genome Atlas Thyroid Carcinoma 9 0.186 1.5
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 1 0.211 1.6